Table 1.
Parameters | Data (n = 787)* |
---|---|
Age at primary diagnosis, median (IQR) | 65 (56–73) |
Female gender, n (%) | 287 (36) |
Occurrence of OMD, n (%) | |
|
179 (23) |
|
586 (74) |
|
20 (3) |
Primary tumors, n/n (%) | |
|
231 (29) |
|
160 (20) |
|
84 (11) |
|
68 (9) |
|
63 (8) |
|
48 (6) |
|
44 (6) |
|
35 (4) |
|
16 (2) |
|
10 (1) |
|
28 (4) |
Frequency of number of distant metastases | |
|
360 (46) |
|
197 (25) |
|
95 (12) |
|
83 (11) |
|
52 (7) |
Abbreviations: CUP = Cancer of unknown primary; GIT = Gastrointestinal tract; IQR = Interquartile range; OMD = Oligometastatic disease.
*We previously reported on 601 individual OMD patients. In the present study, we included repeat OMD scans into our assessment, hence the data on these OMD cases varies slightly from our previous publication [25].
1Includes small-cell lung cancer (SCLC), non-small cell lung cancer (NSCLC) and mesothelioma; 2includes melanoma, squamous cell carcinoma as well as rare skin cancers.